Interested in Connecting? Please contact: Mahesh Narayanan CEO firstname.lastname@example.org
Message the company or request a 1:1 meeting here.
PepVax, Inc. is the parent company of the “Intus” family of companies revolved around it’s DNA-based drug delivery and development platform, SMARTmid™, to develop next generation of cell, gene and immunotherapies for cancers, infections and genetic diseases. PepVax will rely on privately raised financing, licensing fees, and corporate partnerships to fund its operations and capital expenditures to transfer early-stage assets that can benefit from SMARTmid™’s non-viral delivery into spin-outs for clinical development and eventually commercialization. PepVax also plans to create licensing agreements for SMARTmid™ DNA with other biotech companies for drug delivery or therapeutic development.